NY/NJ CEO Biotech Conference to Feature Prominent CEOs -- November 11 & 12

Share Article

Join NASDAQ CEO Bob Greifeld, along with Ron Cohen (Acorda), Carl Gordon (OrbiMed), Maxine Gowen (Trevena), JC Gutierrez-Ramos (Synlogic), Hyam Levitsky (Juno Therapeutics), John Sculley (former Pepsi, Apple), Marc Tessier-Lavigne (Rockefeller), George Yancopoulos (Regeneron) in New York City.

“The NY/NJ CEO conference is a “who’s who” of biopharma and a unique opportunity to connect with some of the best names in the industry” says JC Gutierrez-Ramos, Chief Executive Officer of Synlogic and former senior vice president at Pfizer.

NY/NJ CEO is an off-the-record networking and educational forum for leading executives in life sciences, offering exclusive access to key decision makers who influence deal making and investment. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Healthcare and finance investors also attend this world-class meeting, held November 11-12, 2015, at Apella, 450 East 29th Street, New York City.

Panel topics include 2016 healthcare industry outlook, disruptive innovation and venture philanthropy, non-dilutive financing, pricing and reimbursement, defining the value of drugs, innovation in drug discovery, personalized medicine, creative financing, emerging markets, innovative deal structures, and more.

The NY/NJ CEO Lifetime Achievement Award will be presented Wednesday, November 11 at 5 pm.

“The NY/NJ CEO conference is a “who’s who” of biopharma and a unique opportunity to connect with some of the best names in the industry” says JC Gutierrez-Ramos, Chief Executive Officer of Synlogic and former senior vice president at Pfizer. “The relaxed, off-the record environment makes the conference one of a kind and allows us to brainstorm in an intimate setting. Candid insights and reflections inspire outstanding connections and even deals during the networking breaks. This meeting is not to be missed.”

Additional conference speakers include: Peter Bach (Memorial Sloan Kettering), Harvey Berger (Ariad), Mikael Dolsten (Pfizer), Justin Gover (GW Pharmaceuticals), Tom Heyman (Janssen Pharmaceutica), David Nicholson (Allergan), Vivek Ramaswamy (Axovant), Arthur Tinkelenberg (Enumeral), Malcolm Weir (Heptares), and other prominent industry leaders.

NY/NJ CEO is sponsored by H.C. Wainwright & Co., Fenwick & West LLP, Alexandria, Mintz Levin, L.E.K. Consulting, Skadden and BioPharma Executive Council.

For more information or to register for the conference, visit: http://bbbiotechconference.com/conference-details.php?id=34

ABOUT THE BOSTON BIOTECH CONFERENCES
The Boston Biotech Conferences (BBC)’s mission is to build a vibrant community of biopharma leaders, which will help to drive biopharma innovation in biotech, by convening leaders across industry and academia. The conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking, and corporate development within the biopharma community.

The meetings are invitation-only, off-the-record forums that bring together the past, present, and future leaders in the healthcare community to network, exchange ideas and share insights into the industry's challenges and opportunities. For more information or to register, visit http://www.bbbiotechconference.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Arielle Jackson
@BiotechConf
Follow >
Boston Biotech Conferences
since: 05/2012
Like >
Visit website